Nate Crossett

Stock Analyst at Exane BNP Paribas

(1.92)
# 3,182
Out of 5,122 analysts
38
Total ratings
50%
Success rate
1.19%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Mar 12, 2025
Upgrades: Outperform
Price Target: $5$9
Current: $5.06
Upside: +77.87%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $44.82
Upside: -33.07%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $72.84
Upside: -12.14%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $17.63
Upside: -3.57%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $57.03
Upside: +10.47%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $49.47
Upside: +118.31%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $78.85
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $156.39
Upside: -11.76%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $129.01
Upside: +9.29%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $45.05
Upside: +39.84%
Initiates: Underperform
Price Target: $42
Current: $39.83
Upside: +5.45%
Initiates: Outperform
Price Target: $41
Current: $28.34
Upside: +44.67%
Initiates: Outperform
Price Target: $29
Current: $30.09
Upside: -3.62%
Initiates: Underperform
Price Target: $74
Current: $65.28
Upside: +13.36%
Initiates: Outperform
Price Target: n/a
Current: $13.60
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $8.59
Upside: +11.76%
Initiates: Outperform
Price Target: $66
Current: $83.36
Upside: -20.83%
Initiates: Outperform
Price Target: $38
Current: $13.36
Upside: +184.43%
Initiates: Outperform
Price Target: $886
Current: $769.71
Upside: +15.11%
Downgrades: Hold
Price Target: $31$30
Current: $23.57
Upside: +27.28%
Initiates: Buy
Price Target: $21
Current: $9.03
Upside: +132.56%
Downgrades: Hold
Price Target: $21$25
Current: $9.09
Upside: +175.03%
Upgrades: Buy
Price Target: n/a
Current: $34.60
Upside: -